Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.

Radomski M, Zeh HJ, Edington HD, Pingpank JF, Butterfield LH, Whiteside TL, Wieckowski E, Bartlett DL, Kalinski P.

J Immunother Cancer. 2016 Apr 19;4:24. doi: 10.1186/s40425-016-0128-y. eCollection 2016.

2.

Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.

Wang W, Edington HD, Rao UN, Jukic DM, Radfar A, Wang H, Kirkwood JM.

Clin Cancer Res. 2008 Dec 15;14(24):8314-20. doi: 10.1158/1078-0432.CCR-08-0705.

3.

Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.

Wang W, Edington HD, Jukic DM, Rao UN, Land SR, Kirkwood JM.

Cancer Immunol Immunother. 2008 Sep;57(9):1315-21. doi: 10.1007/s00262-008-0466-9. Epub 2008 Apr 3.

PMID:
18386001
4.

STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.

Wang W, Edington HD, Rao UN, Jukic DM, Wang H, Shipe-Spotloe JM, Kirkwood JM.

J Invest Dermatol. 2008 Aug;128(8):1997-2002. doi: 10.1038/jid.2008.26. Epub 2008 Feb 28.

5.

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.

Okada H, Lieberman FS, Walter KA, Lunsford LD, Kondziolka DS, Bejjani GK, Hamilton RL, Torres-Trejo A, Kalinski P, Cai Q, Mabold JL, Edington HD, Butterfield LH, Whiteside TL, Potter DM, Schold SC Jr, Pollack IF.

J Transl Med. 2007 Dec 19;5:67.

6.

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE.

Clin Cancer Res. 2007 Apr 15;13(8):2422-8.

7.

Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.

Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, Kirkwood JM.

Clin Cancer Res. 2007 Mar 1;13(5):1523-31.

8.

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.

Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D.

Oncogene. 2007 Jun 21;26(29):4216-25. Epub 2007 Feb 12.

PMID:
17297476
9.

Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.

Defail AJ, Edington HD, Matthews S, Lee WC, Marra KG.

J Biomed Mater Res A. 2006 Dec 15;79(4):954-62.

PMID:
16941588
10.
11.

Preemptive analgesia with bupivacaine for segmental mastectomy.

Vallejo MC, Phelps AL, Sah N, Romeo RC, Falk JS, Johnson RR, Keenan DM, Bonaventura MA, Edington HD.

Reg Anesth Pain Med. 2006 May-Jun;31(3):227-32.

PMID:
16701188
12.

Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.

McDonald SL, Edington HD, Kirkwood JM, Becker D.

Cancer Biol Ther. 2004 Jan;3(1):110-20. Epub 2004 Jan 24.

PMID:
14726712
13.

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.

Okada H, Lieberman FS, Edington HD, Witham TF, Wargo MJ, Cai Q, Elder EH, Whiteside TL, Schold SC Jr, Pollack IF.

J Neurooncol. 2003 Aug-Sep;64(1-2):13-20.

PMID:
12952282
15.

Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.

Kirkwood JM, Mascari RA, Edington HD, Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM.

Cancer. 2000 Jun 15;88(12):2693-702.

PMID:
10870051
16.

Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.

Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D.

Mol Med. 1999 Dec;5(12):785-94.

17.

Impaired wound healing and angiogenesis in eNOS-deficient mice.

Lee PC, Salyapongse AN, Bragdon GA, Shears LL 2nd, Watkins SC, Edington HD, Billiar TR.

Am J Physiol. 1999 Oct;277(4):H1600-8. doi: 10.1152/ajpheart.1999.277.4.H1600.

PMID:
10516200
18.

Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

Kirkwood JM, Farkas DL, Chakraborty A, Dyer KF, Tweardy DJ, Abernethy JL, Edington HD, Donnelly SS, Becker D.

Mol Med. 1999 Jan;5(1):11-20.

19.

The effects of soft-tissue expansion on lip repair and midfacial growth in a rabbit cleft lip model.

Edington HD, Mooney MP, Losken A, Hurwitz DJ, Siegel MI.

Ann Plast Surg. 1998 Aug;41(2):171-9.

PMID:
9718151
20.

Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer.

Yamasaki K, Edington HD, McClosky C, Tzeng E, Lizonova A, Kovesdi I, Steed DL, Billiar TR.

J Clin Invest. 1998 Mar 1;101(5):967-71.

21.

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.

Clin Cancer Res. 1997 Mar;3(3):409-17.

22.

Molecular analysis of melanoma precursor lesions.

Wang Y, Rao U, Mascari R, Richards TJ, Panson AJ, Edington HD, Shipe-Spotloe JM, Donnelly SS, Kirkwood JM, Becker D.

Cell Growth Differ. 1996 Dec;7(12):1733-40.

23.
24.

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, et al.

J Immunol. 1994 Aug 15;153(4):1697-706.

PMID:
7913943
25.

Reconstruction of a functional hemidiaphragm with use of omentum and latissimus dorsi flaps.

Edington HD, Evans S, Sindelar WF.

Surgery. 1989 Mar;105(3):442-5.

PMID:
2922678
26.

Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.

Edington HD, Watson CG, Levine G, Tauxe WN, Yousem SA, Unger M, Kowal CD.

Surgery. 1988 Dec;104(6):1004-10.

PMID:
3194829
27.

Management of the surgically traumatized, irradiated, and infected pelvis.

Edington HD, Sugarbaker PH, McDonald HD.

Surgery. 1988 Jun;103(6):690-7.

PMID:
3375995
28.

In vitro and in vivo models for monitoring the adoptive immunotherapeutic effects of recombinant gamma-interferon-activated human monocytes.

Edington HD, Stevenson HC, Sugarbaker PH.

Curr Surg. 1987 May-Jun;44(3):210-3. No abstract available.

PMID:
3109811
29.

V-Y closure for abdominal wall stomal reduction.

Edington HD, Lotze MT.

Surg Gynecol Obstet. 1987 Apr;164(4):381-2.

PMID:
2951883
31.

Prolonged skin allograft survival through enhancement effects on donor tissue.

Deutsch HL, Edington HD, McCullough CM, Sugarbaker PH.

Transplantation. 1986 Aug;42(2):200-4.

PMID:
3526658

Supplemental Content

Loading ...
Support Center